—

Beijing InnoCare Pharma Tech Co., Ltd.

Phase 2 Estimated

ICP-322

Prurigo Nodularis (PN)

Countdown

267days

Phase 2 readout · ~ Mar 31, 2027 estimated

What's at stake Phase 2 trial results for ICP-322 in Prurigo Nodularis (PN) are due ~ Mar 31, 2027. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · ClinicalTrials.gov verified 15h ago

“CT.gov NCT07236099: Phase 2 trial, sponsor Beijing InnoCare Pharma Tech Co., Ltd., drug ICP-322. Primary completion date 2027-03 (estimated).”

Add to calendar Post on X Reddit

Provenance